EZH2 and histone deacetylase inhibitors induce apoptosis in triple negative breast cancer cells by differentially increasing H3 Lys27 acetylation in the BIM gene promoter and enhancers

Breast Cancer Cells ◽

Triple Negative ◽

Gene Promoter

Abstract 1011: Induction of ‘BRCAness’ by treatment with histone deacetylase inhibitors sensitizes human triple negative breast cancer cells to PARP inhibitor and cisplatinum.

10.1158/1538-7445.am2013-1011 ◽

2013 ◽

Author(s):

Warren C. Fiskus ◽

Rekha Rao ◽

Soumyasri Das Gupta ◽

Lata Chauhan ◽

Kapil N. Bhalla

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Triple Negative ◽

Parp Inhibitor

Abstract S3-7: Treatment with Histone Deacetylase Inhibitors Creates ‘BRCAness’ and Sensitizes Human Triple Negative Breast Cancer Cells to PARP Inhibitors and Cisplatin

10.1158/0008-5472.sabcs12-s3-7 ◽

2012 ◽

Cited By ~ 3

Author(s):

KN Bhalla ◽

R Rao ◽

P Sharma ◽

S Das Gupta ◽

L Chauhan ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Triple Negative ◽

Parp Inhibitors

Abstract 5801: Unexpected selectivity of histone deacetylase inhibitors in live MDA-MD-231 triple-negative breast cancer cells

10.1158/1538-7445.am2018-5801 ◽

2018 ◽

Author(s):

Shaimaa M. Aboukhatwa ◽

Thomas W. Hanigan ◽

Jayaprakash Neerasa ◽

Taha Y. Taha ◽

Nathan D. Brown ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Triple Negative

Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors

Journal of Experimental & Clinical Cancer Research ◽

10.1186/s13046-018-0988-8 ◽

2018 ◽

Vol 37 (1) ◽

Cited By ~ 21

Author(s):

Yanrong Su ◽

Nathan R. Hopfinger ◽

Theresa D. Nguyen ◽

Thomas J. Pogash ◽

Julia Santucci-Pereira ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Dna Methyltransferase ◽

Triple Negative ◽

Epithelial Mesenchymal Transition ◽

Mesenchymal Transition

Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells

Cellular Signalling ◽

10.1016/j.cellsig.2016.02.006 ◽

2016 ◽

Vol 28 (5) ◽

pp. 506-515 ◽

Cited By ~ 37

Author(s):

Zhao-Tong Wang ◽

Zhuo-Jia Chen ◽

Guan-Min Jiang ◽

Ying-Min Wu ◽

Tao Liu ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Triple Negative ◽

Mutant P53

Abstract 423: Epigenetic reprogramming of epithelial-mesenchymal transition in triple-negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors

10.1158/1538-7445.am2014-423 ◽

2014 ◽

Author(s):

Yanrong Su ◽

Nathan R. Hopfinger ◽

Thomas J. Pogash ◽

Theresa D. Nguyen ◽

Julia Santucci-Pereira ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Dna Methyltransferase ◽

Triple Negative ◽

Epithelial Mesenchymal Transition ◽

Mesenchymal Transition

Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals

European Journal of Pharmacology ◽

10.1016/j.ejphar.2018.12.030 ◽

2019 ◽

Vol 845 ◽

pp. 16-23 ◽

Cited By ~ 10

Author(s):

Panpan An ◽

Jiexin Li ◽

Linlin Lu ◽

Yingmin Wu ◽

Yuyi Ling ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Triple Negative ◽

Histone Deacetylase 8

Abstract 5847: A histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth with apoptosis in triple-negative breast cancer cells

10.1158/1538-7445.am2018-5847 ◽

2018 ◽

Author(s):

Hisako Ono ◽

Yoshihiro Sowa ◽

Yosuke Iizumi ◽

Mano Horinaka ◽

Tetsuya Taguchi ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Breast Cancer Cells ◽

Triple Negative ◽

Deacetylase Inhibitor

Biological Effect of a Hybrid Anticancer Agent Based on Kinase and Histone Deacetylase Inhibitors on Triple-Negative (MDA-MB231) Breast Cancer Cells

International Journal of Molecular Sciences ◽

10.3390/ijms17081235 ◽

2016 ◽

Vol 17 (8) ◽

pp. 1235 ◽

Cited By ~ 9

Author(s):

Mariangela Librizzi ◽

John Spencer ◽

Claudio Luparello

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Biological Effect ◽

Breast Cancer Cells ◽

Anticancer Agent ◽

Triple Negative ◽

Agent Based

Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-14-0778 ◽

2015 ◽

Vol 14 (8) ◽

pp. 1848-1857 ◽

Cited By ~ 41

Author(s):

Amanda Schech ◽

Armina Kazi ◽

Stephen Yu ◽

Preeti Shah ◽

Gauri Sabnis

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Breast Cancer Cells ◽

Triple Negative ◽

Tumor Initiating Cells ◽

Deacetylase Inhibitor